Improving Diagnostic Precision: Phenotype-Driven Analysis Uncovers a Maternal Mosaicism in an Individual with RYR1-Congenital Myopathy


Por: Estévez-Arias B, Matalonga L, Martorell-Sampol L, Codina-Bergadà A, Ortez-Gonzalez CI, Carrera-García L, Exposito-Escudero JM, Yubero-Siles D, Hoenicka J, Jou-Munoz C, Palau F, Beltran S, Lochmüller H, Töpf A, Nascimento-Osorio A and Natera-de Benito D

Publicada: 1 ene 2024 Ahead of Print: 10 mar 2024
Resumen:
Congenital myopathies (CMs) are rare genetic disorders for which the diagnostic yield does not typically exceed 60%. We performed deep phenotyping, histopathological studies, clinical exome and trio genome sequencing and a phenotypedriven analysis of the genomic data, that led to the molecular diagnosis in a child with CM. We identified a heterozygous variant in RYR1 in the affected child, inherited from her asymptomatic mother. Given the alignment of the clinical and histopathological phenotype with RYR1-CM, we considered the potential existence of a missing second variant in trans in the proband, but also hypothesized that the variant might be mosaic in the mother, as subsequently demonstrated. Our study is an example of how heterozygous variants inherited from asymptomatic parents are frequently dismissed. When the genotype-phenotype correlation is strong, it is recommended to consider a parental mosaicism.

Filiaciones:
Estévez-Arias B:
 Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain

 Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Matalonga L:
 Centro Nacional Análisis Genómico (CNAG), Barcelona, Spain

Martorell-Sampol L:
 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

 Department of Genetic and Molecular Medicine - IPER, Hospital Sant Joan de Déu and Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Codina-Bergadà A:
 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain

Ortez-Gonzalez CI:
 Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain

 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Carrera-García L:
 Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain

 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Exposito-Escudero JM:
 Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain

 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Yubero-Siles D:
 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

 Department of Genetic and Molecular Medicine - IPER, Hospital Sant Joan de Déu and Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Hoenicka J:
 Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

Jou-Munoz C:
 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain

Palau F:
 Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

 Department of Genetic and Molecular Medicine - IPER, Hospital Sant Joan de Déu and Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 ERN ITHACA, Barcelona, Spain

 Division of Pediatrics, Faculty of Medicine and Health Sciences, Universitat de Barcelona (UB), Barcelona, Spain

Beltran S:
 Centro Nacional Análisis Genómico (CNAG), Barcelona, Spain

 Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona (UB), Barcelona, Spain

Lochmüller H:
 Centro Nacional Análisis Genómico (CNAG), Barcelona, Spain

 Childrens Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada

 Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, Canada

Töpf A:
 The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK

Nascimento-Osorio A:
 Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain

 Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain

 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Natera-de Benito D:
 Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain

 Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain
ISSN: 22143599





Journal of Neuromuscular Diseases
Editorial
SAGE PUBLICATIONS INC, 2455 TELLER RD, THOUSAND OAKS, CA 91320, Países Bajos
Tipo de documento: Article
Volumen: 11 Número: 3
Páginas: 647-653
WOS Id: 001212193400006
ID de PubMed: 38489196
imagen Green Submitted, Bronze

FULL TEXT

imagen Published Version https://www.iospress.com/author-copyright-agreement

MÉTRICAS